The groundbreaking therapy of this peptide represents a significant advance in the care of diabetes mellitus type 2. Different to existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide804993.isblog.net/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-59391732